Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diffuse large B-cell lymphoma (DLBCL)
Pharma
FDA rejects Roche's earlier DLBCL bid over lackluster US data
The FDA suggested that Columvi's phase 3 data do not provide enough evidence to support the proposed indication in a U.S. population, Roche said.
Angus Liu
Jul 18, 2025 1:32pm
China approves 4 new drugs, including global 1st-in-class
Jul 2, 2025 11:32am
Roche’s bispecific-ADC combo keeps lymphoma at bay
Jun 23, 2025 10:27am
FDA leaders push for more US enrollment in cancer trials
May 20, 2025 12:52pm
J&J, Pfizer and Roche face FDA questions over data applicability
May 16, 2025 3:52pm
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
